Mylan Laboratories Limited

Form 483 issued September 17, 2021 · Hosur, India

Inspection
Sep 6 – Sep 17, 2021
Investigator
Rita K. Kabaso
Observations
5
Pages
7
FEI number
3008255419

In short: On September 17, 2021, FDA issued a Form 483 with 5 observations to Mylan Laboratories Limited in Hosur, Tamil Nadu (FEI 3008255419) after an inspection that ran Sep 6 – Sep 17, 2021. The investigator was Rita K. Kabaso. Most observations concern facilities & equipment and production; the most-cited regulation is 21 CFR 211.42 (design and construction features).

At a glance

3 of 5 observations on this 483 concern facilities & equipment.

Facilities & equipment3
Production1
Quality system1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Aseptic processing areas are deficient regarding the system…

  2. 02

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile did not include…

  3. 03

    Employees engaged in the manufacture of a drug product lack the education, training and experience required…

  4. 04

    Aseptic processing areas are deficient regarding systems for maintaining any equipment used to…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Mylan Laboratories Limited?

FDA listed 5 observations on this Form 483, mostly about facilities & equipment, production and quality system. The most-cited regulation is 21 CFR 211.42 (design and construction features). The opening words of each observation are shown on this page.

Who inspected Mylan Laboratories Limited?

Rita K. Kabaso is named on this Form 483, for the inspection of Sep 6 – Sep 17, 2021. Each investigator has a profile showing what they cite most.

When was Mylan Laboratories Limited inspected by FDA?

The inspection ran Sep 6 – Sep 17, 2021, and the Form 483 is dated September 17, 2021.

How do I get the full Form 483 for Mylan Laboratories Limited?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free